Across TCGA pan-cancer cohorts, SPIN2B Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated SPIN2B data layer compared with 22 for mass-spec protein.
The strongest signal is observed in adrenocortical carcinoma (ACC), where higher SPIN2B Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated SPIN2B expression acts as an unfavorable survival marker.
ACC and LUSC are the cancer types where SPIN2B Mutation most reproducibly stratifies survival.